NHLS Cancer Test Outsourcing Hits R116m As Backlog Cleared

NHLS cancer test outsourcing cost R116m to clear backlogs, raising sustainability concerns amid tight healthcare budgets.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Aaron Motsoaledi, Ampath, cancer test backlog, diagnostic delays, Healthcare Funding, Lancet Laboratories, NHLS, Pathcare, pathology outsourcing, private labs, public health system, South Africa health crisis